Skip to main content
OpenTrials
Completed

NCT Number: NCT00229476

Study of Medication and Placebo Response in Major Depression

The primary purpose of the research study is to use recordings of brain electrical activity (through electroencephalogram, or EEG) and symptom measurements to determine whether patients are likely to show a response to medication or placebo treatment during a treatment trial for depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Disorder, Major Behavior Behavioral Symptoms Depression Depressive Disorder Mental Disorders Mood Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

UCLA Neuropsychiatric Institute & Hospital

Los Angeles, California, 90024, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical Diagnosis of Unipolar Major Depression

Exclusion criteria

  • Substance Abuse, Psychotic Disorder, History of Severe Head Trauma

Treatment and study plan

sertraline (Zoloft)

Drug

Primary outcomes

  1. depressive symptoms

Secondary outcomes

  1. brain electrical activity (EEG)

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Collaborators

  • Eli Lilly and Company
  • Massachusetts General Hospital
  • Pfizer

Registry information

Important dates

Study start
2003
Primary completion
2006
First posted
Sep 29, 2005
Registry last updated
Nov 7, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.